HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

F España Selected Research

Venous Thromboembolism

3/2014Functional analysis of two haplotypes of the human endothelial protein C receptor gene.
12/2001Low level of circulating activated protein C is a risk factor for venous thromboembolism.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


F España Research Topics

Disease

5Endometriosis
02/2010 - 07/2003
3Cardiovascular Diseases (Cardiovascular Disease)
01/2009 - 01/2001
3Venous Thrombosis (Deep-Vein Thrombosis)
02/2006 - 10/2000
3Prostatic Neoplasms (Prostate Cancer)
11/2002 - 07/2000
2Thrombophilia
01/2016 - 12/2000
2Thrombosis (Thrombus)
01/2016 - 12/2000
2Venous Thromboembolism
03/2014 - 12/2001
2Myocardial Infarction
10/2008 - 07/2006
2Obesity
01/2007 - 08/2001
2Coronary Artery Disease (Coronary Atherosclerosis)
07/2006 - 01/2001
2Cysts
01/2005 - 07/2003
2Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
11/2002 - 07/2000
1Congenital Disorders of Glycosylation
01/2016
1von Willebrand Diseases (von Willebrand's Disease)
11/2013
1Hemophilia A (Haemophilia)
03/2013
1Heart Diseases (Heart Disease)
01/2009
1Hypertrophy
01/2009
1Cardiac Sudden Death (Sudden Cardiac Arrest)
01/2009
1Heart Failure
01/2009
1Ovarian Cysts (Ovarian Cyst)
10/2007
1Insulin Resistance
01/2007
1Weight Loss (Weight Reduction)
08/2001
1Inflammation (Inflammations)
06/2001
1Necrosis
06/2001
1Congenital Abnormalities (Deformity)
12/2000

Drug/Important Bio-Agent (IBA)

4Proteins (Proteins, Gene)FDA Link
03/2014 - 01/2005
4Protein CIBA
07/2006 - 06/2001
4Plasminogen Activators (Plasminogen Activator)IBA
01/2006 - 10/2000
4Plasminogen Activator Inhibitor 1IBA
01/2005 - 10/2000
3Messenger RNA (mRNA)IBA
02/2010 - 01/2005
3Urokinase-Type Plasminogen Activator (Urokinase)FDA Link
08/2007 - 07/2003
3Matrix Metalloproteinases (MMPs)IBA
08/2007 - 07/2003
2von Willebrand FactorIBA
11/2013 - 06/2001
2ThrombinFDA Link
03/2013 - 06/2001
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2010 - 08/2007
2Fibrinogen (Factor I)FDA Link
01/2007 - 06/2001
2Tissue Inhibitor of Metalloproteinase-1IBA
01/2005 - 07/2003
2Prostate-Specific Antigen (Semenogelase)IBA
11/2002 - 07/2000
2alpha 1-Antichymotrypsin (alpha 1 Antichymotrypsin)IBA
04/2001 - 07/2000
1AntithrombinsIBA
01/2016
1Transferrin (beta 2 Transferrin)IBA
01/2016
1Glycoproteins (Glycoprotein)IBA
01/2016
1Endothelial Protein C ReceptorIBA
03/2014
1Factor VIII (Coagulation Factor VIII)IBA
03/2013
1Biological ProductsIBA
01/2009
1Transcription Factors (Transcription Factor)IBA
01/2009
1MicroRNAs (MicroRNA)IBA
01/2009
1Interleukin-4 (Interleukin 4)IBA
10/2008
1ProgesteroneFDA LinkGeneric
10/2007
1Metalloproteases (Metalloproteinases)IBA
08/2007
1AnticoagulantsIBA
07/2006
1Finasteride (Propecia)FDA LinkGeneric
11/2002
1Plasminogen InactivatorsIBA
08/2001
1LipidsIBA
08/2001
1TrypsinIBA
06/2001
1FibrinolysinFDA Link
06/2001
1FibrinIBA
06/2001
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
06/2001
1C-Reactive ProteinIBA
06/2001
1CytokinesIBA
06/2001
1Interleukin-8 (Interleukin 8)IBA
06/2001
1Acute-Phase Proteins (Acute-Phase Protein)IBA
06/2001
1Lipoprotein(a)IBA
01/2001
1Oral ContraceptivesIBA
12/2000
1Prothrombin (Factor II)IBA
12/2000
1factor V LeidenIBA
12/2000

Therapy/Procedure

1Hormone Replacement Therapy (Therapy, Hormone Replacement)
01/2001
1Transurethral Resection of Prostate (TURP)
07/2000
1Prostatectomy (Retropubic Prostatectomy)
07/2000